Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A143MK | ISIN: GB00BY7QYJ50 | Ticker-Symbol: GRW
Frankfurt
21.01.25
15:29 Uhr
3,440 Euro
+0,060
+1,78 %
1-Jahres-Chart
MOLTEN VENTURES PLC Chart 1 Jahr
5-Tage-Chart
MOLTEN VENTURES PLC 5-Tage-Chart
RealtimeGeldBriefZeit
3,3803,70021.01.
Dow Jones News
197 Leser
Artikel bewerten:
(1)

Molten Ventures Plc: Share Repurchase Programme

Finanznachrichten News

DJ Share Repurchase Programme

Molten Ventures Plc (GROW; GRW) 
Share Repurchase Programme 
21-Jan-2025 / 07:00 GMT/BST 
=---------------------------------------------------------------------------------------------------------------------- 
Molten Ventures plc 
("Molten Ventures", "Molten", "the "Group" or the "Company") 
Share Repurchase Programme 
Molten Ventures (LSE: GROW, Euronext Dublin: GRW), a leading venture capital firm investing in and developing 
high-growth digital technology businesses, confirms that following its announcement regarding the exit of its Freetrade 
position and the Company's intention to commence a share repurchase programme of a further GBP5m (the "Programme"), it 
will today commence the Programme and will continue until the earlier of either the expiration of the general authority 
received at the Company's 2024 AGM ("General Authority") or reaching purchase of the maximum amount intended under the 
Programme. 
The purchased ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") will be held in 
treasury. 
To implement the Programme, the Company has entered into an irrevocable, non-discretionary agreement with Numis 
Securities Limited ("Deutsche Numis") to conduct the Programme on its behalf and carry out on-market purchases of 
Ordinary Shares, acting as riskless principal, and to sell on such Ordinary Shares to the Company. Share repurchases 
may be made from time to time depending on market conditions, share price and trading volume. 
The Company confirms that it currently has no unpublished inside information. 
The Programme will operate in accordance with and under the terms of the relevant General Authority. The Programme will 
be conducted within the parameters of the Market Abuse Regulation 596/2014/EU and the delegated regulations made 
pursuant to it. 
As at 30 September 2024, the Company's total issued share capital consisted of 189,046,450 Ordinary Shares. The total 
number of Ordinary Shares in treasury is 2,574,540 and the total number of voting rights in the Company is 186,471,910. 
The Company will announce any market repurchase of Ordinary Shares no later than 7.30am on the business day following 
the calendar day on which the repurchase occurred. 
 -ENDS- 
Enquiries 
Molten Ventures plc 
                          +44 (0)20 7931 8800 
Ben Wilkinson (Chief Executive Officer) 
                          ir@molten.vc 
Andrew Zimmermann (Interim Chief Financial Officer) 
Deutsche Numis 
Joint Financial Adviser and Corporate Broker 
Simon Willis                    +44 (0)20 7260 1000 
Jamie Loughborough 
Iqra Amin 
Goodbody Stockbrokers 
Joint Financial Adviser and Corporate Broker, 
Euronext Dublin Sponsor 
                          +44 (0) 20 3841 6202 
Don Harrington 
Tom Nicholson 
William Hall 
Sodali 
                          +44 (0)7970 246 725/ 
Public relations 
                          +44 (0)771 324 6126 
Elly Williamson 
                          molten@sodali.com 
Jane Glover About Molten Ventures 

Molten Ventures is a leading venture capital firm in Europe, developing and investing in disruptive, high growth technology companies. We inject visionary companies with energy to help them transform and grow. This energy comes in many forms - capital, of course, but also knowledge, experience, and relationships. We believe it is our role to support the entrepreneurs who will invent the future, and that future is being built, today, in Europe.

As at 30 September 2024, Molten Ventures had a diverse portfolio with shareholdings in 100+ companies, 18 of which represent our Core Portfolio holdings and account for 61% of the Gross Portfolio Value. Our core companies include Revolut, Thought Machine, Coachhub, Form3, Aiven, Ledger and Aircall. We invest across four sectors: Enterprise Technology, Hardware and Deeptech, Consumer Technology, and Digital Health and Wellness, with highly experienced partners constantly looking for new opportunities in each. We look for high-growth companies operating in new markets, with aspirations for global expansion, strong IP, powerful technology, and strong management teams to deliver success. We also look for businesses with the potential to generate strong margins to ensure rapid, sustainable growth in substantial addressable markets.

Molten Ventures provides a unique opportunity for public market investors to access these fast-growing tech businesses, without having to commit to long term investments with limited liquidity. Since our IPO in June 2016, we have deployed over GBP1bn capital into fast growing tech companies and have realised over GBP600 million to 30 September 2024.

For more information, go to https://investors.moltenventures.com/investor-relations/plc

----------------------------------------------------------------------------------------------------------------------- Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

ISIN:      GB00BY7QYJ50 
Category Code: POS 
TIDM:      GROW; GRW 
LEI Code:    213800IPCR3SAYJWSW10 
OAM Categories: 2.4. Acquisition or disposal of the issuer's own shares 
        2.5. Total number of voting rights and capital 
Sequence No.:  371641 
EQS News ID:  2071065 
 
End of Announcement EQS News Service 
=------------------------------------------------------------------------------------
 

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=2071065&application_name=news&site_id=dow_jones%7e%7e%7ef1066a31-ca00-4e1a-b0a4-374bd7d0face

(END) Dow Jones Newswires

January 21, 2025 02:00 ET (07:00 GMT)

© 2025 Dow Jones News
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.